ISTO Technologies, Inc.
1155 Olivette Exective Parkway
Suite 100
St. Louis
Missouri
63132
United States
Tel: 314-995-6049
Fax: 314-995-6025
Website: http://www.istotech.com/
Email: info@istotech.com
26 articles about ISTO Technologies, Inc.
-
ISTO Technologies, Inc. To Present At The 2015 Canaccord Genuity Musculoskeletal Conference On March 24, 2015
3/18/2015
-
ISTO Technologies, Inc. To Present At The Oppenheimer 25th Annual Healthcare Conference
12/5/2014
-
ISTO Technologies, Inc. To Present At 2014 Stifel Healthcare Conference
11/11/2014
-
ISTO Technologies, Inc. To Present At 12th Annual 2014 Musculoskeletal New Ventures Conference
10/21/2014
-
ISTO Technologies, Inc. To Present At 2014 Stem Cell Meeting On The Mesa
9/30/2014
-
Phillip W. Kuhn Appointed Chief Commercial Officer Of ISTO Technologies, Inc.
4/8/2014
-
ISTO Technologies, Inc. Names George W. Dunbar, Jr. President And Chief Executive Officer
1/9/2014
-
ISTO Technologies, Inc. Appoints James McGorry To Board Of Directors
1/7/2014
-
ISTO Technologies, Inc. Awarded Spine Technology Award for NuQu® Technology
10/25/2012
-
ISTO Technologies, Inc. Initiates Phase II Trial of NuQu®: Novel Cell-Based Therapy for the Treatment of Painful Spinal Discs
10/22/2012
-
Zimmer and ISTO Technologies, Inc. Announce Phase III Clinical Study to Evaluate the Effectiveness of Engineered Juvenile Cartilage to Repair Damaged Knees
2/8/2012
-
ISTO Technologies, Inc. Receives CE Mark for InQu(R) Bone Graft Substitute and Extender
10/13/2011
-
ISTO Technologies, Inc. to Present at Canaccord Genuity's Musculoskeletal Conference
2/10/2011
-
ISTO Technologies, Inc. Awarded Key Patent for NuQu(TM) Injectable Therapy for Degenerative Disc Disease
2/7/2011
-
ISTO Technologies, Inc. Completes Enrollment in Phase I NuQu Clinical Trial
10/5/2010
-
ISTO Technologies, Inc. to Present at the Jefferies 2010 Global Life Sciences Conference
6/1/2010
-
ISTO Technologies, Inc. to Present at the Canaccord Adams Musculoskeletal Conference
2/16/2010
-
ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
4/28/2009
-
ISTO Technologies, Inc. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
10/16/2008
-
ISTO Technologies, Inc. to Present at 2nd Annual Jefferies & Company, Inc. Healthcare Conference
6/4/2008